Enveric Biosciences, Inc. Profile Avatar - Palmy Investing

Enveric Biosciences, Inc.

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related di…

Biotechnology
US, Naples [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of ENVB's Analysis
CIK: 890821 CUSIP: 29405E208 ISIN: US29405E2081 LEI: - UEI: -
Secondary Listings
ENVB has no secondary listings inside our databases.